Rankings
▼
Calendar
MCK Q3 2022 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena
MCK
McKesson Corporation
$115B
Q3 2022 Earnings
Healthcare
Medical - Distribution
Income Statement
Revenue
$68.6B
+9.6% YoY
Gross Profit
$3.3B
4.8% margin
Operating Income
$323M
0.5% margin
Net Income
-$7M
-0.0% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
+3.1%
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.3B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$63.7B
Total Liabilities
$64.5B
Stockholders' Equity
-$1.3B
Cash & Equivalents
$2.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$68.6B
$62.6B
+9.6%
Gross Profit
$3.3B
$3.0B
+10.1%
Operating Income
$323M
$894M
-63.9%
Net Income
-$7M
-$6.2B
+99.9%
Revenue Segments
U.S. Pharmaceutical Segment
$55.0B
80%
International Segment
$9.5B
14%
Medical-Surgical Solutions Segment
$3.1B
4%
Prescription Technology Solutions
$1.0B
2%
← FY 2022
All Quarters
Q4 2022 →